Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02365090 · ClinicalTrials.gov registry record · NA

Binocular iPad Sub-Study

A NA study of Amblyopia, sponsored by Retina Foundation of the Southwest.

Active
Registry status
NA
Development phase
96
Enrollment target
1
Study location

NCT02365090 is a NA study of Amblyopia that is active but no longer recruiting, run by Retina Foundation of the Southwest. The registered enrollment target is 96 participants, below the 162-participant average among 24 other Amblyopia trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02365090, a NA study of Amblyopia, is active but no longer recruiting, sponsored by Retina Foundation of the Southwest.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
96 participants
Enrollment target
1
Study location

Study Summary

1. To determine whether a binocular iPad game app is effective in improving visual acuity and reducing interocular suppression in amblyopic children 2. To compare the amount of visual acuity improvement achieved with the binocular game app to the amount achieved with patching (standard treatment for amblyopia)

Conditions Studied

Interventions

  • OTHER patching
  • OTHER binocular games

Study Locations (1)

Texas

  • Retina Foundation of the Southwest - Dallas

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 2015-02
Est. Completion 2025-12
Phase NA

Sponsor

Retina Foundation of the Southwest

11 total trials

What the Registry Record Tells You About NCT02365090

The ClinicalTrials.gov registry entry for NCT02365090 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 162-participant average among 24 other Amblyopia trials with a reported enrollment target (41% lower). The listed sponsor is Retina Foundation of the Southwest, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Amblyopia appearing as the primary indexed condition, and to 2 interventions - of which patching is the first listed.

NCT02365090 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02365090 about?

NCT02365090 is a clinical study titled "Binocular iPad Sub-Study". 1. To determine whether a binocular iPad game app is effective in improving visual acuity and reducing interocular suppression in amblyopic children 2. To compare the amount of visual acuity improvement achieved with the binocular game app to the amount achieved with patching (standard treatment for...

What is the current status of trial NCT02365090?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 96 participants. The study started on 2015-02. Estimated completion is 2025-12.

What conditions does trial NCT02365090 study?

This clinical trial studies the following conditions: Amblyopia.

What interventions are being tested in trial NCT02365090?

The interventions under investigation include: patching (OTHER), binocular games (OTHER).

Who is sponsoring clinical trial NCT02365090?

This trial is sponsored by Retina Foundation of the Southwest, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02365090 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amblyopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.